Novel peptide ‘kills’ cancer cells more effective than current therapies
January 23rd, 2011 - 2:51 pm ICT by ANIWashington, Jan 23 (ANI): Scientists have discovered a novel peptide that can act as a potent inducer of cancer cell death, which may have significant implications for therapeutic agents used to treat cancer.
Researchers from UMDNJ-Robert Wood Johnson Medical School suggested that the amphipathic tail-anchoring peptide, or ATAP, might provide more successful outcomes in cancer treatment than the BH3 peptide-based therapy currently used.
Recent advances in cancer research have focused on the use of peptides to initiate apoptosis, or the death of cancer cells. Bcl-2 homology domain-3 (BH3) peptides are potent therapeutic agents that are currently used in cancer treatment.
However, BH3-based therapy has some limitations, as cancer cells often acquire resistance to treatment by producing anti-apoptic proteins that inhibit this type of treatment.
In studying alternate strategies to induce cancer cell death, the researchers discovered that ATAP was unaffected by anti-apoptic proteins and could successfully induce the death of cancer cells that are resistant to BH3-mediated therapy.
“Our study indicates that ATAP has a potential advantage over BH3 peptides as a therapeutic agent for cancer because it evades anti-apoptic proteins that cause cancer tumors to become resistant to therapy,” said Jianjie Ma, lead author of the study.
The study was published in the Journal of Biological Chemistry. (ANI)
- Protein that makes tumor cells in breast cancer resistant to treatments - Dec 15, 2010
- Motor protein that blocks ovarian tumor growth found - Apr 27, 2011
- Protein that protects cancer cells from chemo, radiation therapy found - Mar 25, 2011
- Scientists find new way to 'starve' cancer cells - Apr 05, 2011
- Molecule able to fight brain cancer found - Apr 22, 2011
- Latin brew bumps off colon cancer cells - Jan 24, 2012
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
- New personalized therapy to 'fool cancer cells into killing themselves' - Mar 01, 2011
- Adopting 'synthetic lethality' could boost molecularly targeted cancer therapy - Sep 22, 2010
- Novel therapy may eradicate lung cancer - Oct 30, 2009
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
- New treatment shows promise in the fight against breast cancer - Mar 30, 2011
- Peptide to enhance cancer drug effectiveness - Apr 09, 2010
- Potential therapeutic target for breast cancer identified - Apr 06, 2011
- Nanoparticle 'smart bomb' formed by bee venom may harbour cancer cure - Aug 03, 2010
Tags: advances in cancer research, alternate strategies, apoptosis, cancer cell, cancer cells, cancer researchers, cancer treatment, cancer tumors, cell death, homology, johnson medical school, journal of biological chemistry, novel peptide, peptides, potent inducer, robert wood johnson medical, robert wood johnson medical school, therapeutic agent, therapeutic agents, wood johnson medical school